Pharmaceuticals, Biotechnology and Life Sciences
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in…
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article…
Topline data from pivotal Phase 3 Iocyte AMI-3 trial expected in Q4 2025SEATTLE, Sept. 11, 2025 (GLOBE NEWSWIRE) — Faraday…
Leading KOLs to discuss the unmet needs and current treatment landscapes of idiopathic inflammatory myopathy (IIM), ulcerative colitis (UC), rheumatoid…
Press release – No.13 / 2025 SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December…
CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company…
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (“LB Pharmaceuticals”) today announced the pricing of its upsized initial…
WINNIPEG, Manitoba, Sept. 10, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or “Kane”) today announces that it…
Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and DiscoveryFREMONT, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) — With cancer research…
– Second-generation constructs induce robust increases in fecal IgA, which was shown to be correlated with protection against infection in…